Literature DB >> 9085256

TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis.

H Y Lan1, N Yang, C Metz, W Mu, Q Song, D J Nikolic-Paterson, M Bacher, R Bucala, R C Atkins.   

Abstract

BACKGROUND: Macrophage migration inhibitory factor (MIF) is a potent proinflammatory mediator that participates in the pathogenesis of endotoxemia and experimental crescentic glomerulonephritis. However, very little is known about how MIF production is regulated in disease. We therefore examined whether tumor necrosis factor alpha (TNF-alpha), a known inducer of MIF expression by macrophages in vitro, up-regulates local and systemic MIF expression in a macrophage-mediated rat model of crescentic glomerulonephritis.
MATERIALS AND METHODS: Anti-glomerular basement membrane (GBM) glomerulonephritis was induced in groups of six primed rats. Animals were treated with 1 mg/kg soluble TNF-alpha receptor (TNFbp) or saline from the time of disease induction until they were killed on Days 1, 7, or 14. Renal MIF expression was assessed by in situ hybridization, immunohistochemistry, and ELISA, and compared with macrophage accumulation and indices of renal damage.
RESULTS: Although TNFbp treatment on Day 1 of the disease had only a partial effect upon the up-regulation of glomerular MIF expression, on Days 7 to 14 it almost completely abrogated the increase in glomerular and interstitial MIF mRNA and protein expression. In addition, TNFbp treatment significantly inhibited MIF secretion by cultured glomeruli and reduced serum MIF levels. The inhibition of renal MIF expression was paralleled by a significant inhibition of glomerular and interstitial macrophage infiltration (p < 0.001 versus saline treated), a significant suppression of renal injury (proteinuria and serum creatinine), and a marked reduction in histologic damage (glomerular hypercellularity, crescent formation, and interstitial fibrosis; all p < 0.01 versus saline treated).
CONCLUSIONS: This study demonstrates for the first time that TNF-alpha up-regulates local MIF expression by both infiltrating macrophages and resident kidney cells in rat crescentic glomerulonephritis. In addition, TNF-alpha regulates systemic MIF production. Thus, TNF-alpha, together with MIF, may play a pathological role in immunologically induced renal disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9085256      PMCID: PMC2230061     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  23 in total

1.  Migration inhibitory factor expression in experimentally induced endotoxemia.

Authors:  M Bacher; A Meinhardt; H Y Lan; W Mu; C N Metz; J A Chesney; T Calandra; D Gemsa; T Donnelly; R C Atkins; R Bucala
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

2.  Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.

Authors:  J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1966-07       Impact factor: 11.205

3.  The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3.

Authors:  C D Dijkstra; E A Döpp; P Joling; G Kraal
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

4.  Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.

Authors:  B R Bloom; B Bennett
Journal:  Science       Date:  1966-07-01       Impact factor: 47.728

5.  Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation.

Authors:  A A Beg; T S Finco; P V Nantermet; A S Baldwin
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

6.  Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis.

Authors:  H Y Lan; D J Paterson; R C Atkins
Journal:  Kidney Int       Date:  1991-09       Impact factor: 10.612

7.  Antiserum against tumor necrosis factor-alpha and a protease inhibitor reduce immune glomerular injury.

Authors:  Z W Hruby; K Shirota; S Jothy; R P Lowry
Journal:  Kidney Int       Date:  1991-07       Impact factor: 10.612

8.  Human recombinant migration inhibitory factor activates human macrophages to kill tumor cells.

Authors:  L A Pozzi; W Y Weiser
Journal:  Cell Immunol       Date:  1992-12       Impact factor: 4.868

9.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia.

Authors:  J Bernhagen; T Calandra; R A Mitchell; S B Martin; K J Tracey; W Voelter; K R Manogue; A Cerami; R Bucala
Journal:  Nature       Date:  1993-10-21       Impact factor: 49.962

10.  Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.

Authors:  K Nishikawa; Y J Guo; M Miyasaka; T Tamatani; A B Collins; M S Sy; R T McCluskey; G Andres
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

View more
  19 in total

1.  Macrophage apoptosis in rat crescentic glomerulonephritis.

Authors:  H Y Lan; H Mitsuhashi; Y Y Ng; D J Nikolic-Paterson; N Yang; W Mu; R C Atkins
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Urine macrophage migration inhibitory factor (MIF) in children with urinary tract infection: a possible predictor of acute pyelonephritis.

Authors:  Hasan Otukesh; Seyed-Mohammad Fereshtehnejad; Rozita Hoseini; Sepideh Hekmat; Hamid Chalian; Majid Chalian; Arash Bedayat; Reza Salman Yazdi; Saeed Sabaghi; Saeed Mahdavi
Journal:  Pediatr Nephrol       Date:  2008-09-18       Impact factor: 3.714

Review 3.  Inflammatory processes in renal fibrosis.

Authors:  Xiao-Ming Meng; David J Nikolic-Paterson; Hui Yao Lan
Journal:  Nat Rev Nephrol       Date:  2014-07-01       Impact factor: 28.314

4.  Tangshen formula improves inflammation in renal tissue of diabetic nephropathy through SIRT1/NF-κB pathway.

Authors:  Yue-Guang Du; Ke-Na Zhang; Zong-Lei Gao; Fengjiao Dai; Xi-Xi Wu; Ke-Fu Chai
Journal:  Exp Ther Med       Date:  2017-12-12       Impact factor: 2.447

5.  C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent Kidney Injury by Limiting Renal Macrophage Infiltration.

Authors:  Nathan P Rudemiller; Mehul B Patel; Jian-Dong Zhang; Alexander D Jeffs; Norah S Karlovich; Robert Griffiths; Matthew J Kan; Anne F Buckley; Michael D Gunn; Steven D Crowley
Journal:  Am J Pathol       Date:  2016-09-15       Impact factor: 4.307

6.  Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis.

Authors:  Volker Vielhauer; George Stavrakis; Tanya N Mayadas
Journal:  J Clin Invest       Date:  2005-04-01       Impact factor: 14.808

7.  Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.

Authors:  Li Chen; Xia Zhou; Lucy X Fan; Ying Yao; Katherine I Swenson-Fields; Mihaela Gadjeva; Darren P Wallace; Dorien J M Peters; Alan Yu; Jared J Grantham; Xiaogang Li
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

8.  Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): potential role of MIF in regulating glucocorticoid production.

Authors:  N Yang; D J Nikolic-Paterson; Y Y Ng; W Mu; C Metz; M Bacher; A Meinhardt; R Bucala; R C Atkins; H Y Lan
Journal:  Mol Med       Date:  1998-06       Impact factor: 6.354

9.  Blocking Macrophage Migration Inhibitory Factor Protects Against Cisplatin-Induced Acute Kidney Injury in Mice.

Authors:  Jinhong Li; Ying Tang; Patrick M K Tang; Jun Lv; Xiao-Ru Huang; Christine Carlsson-Skwirut; Lydie Da Costa; Anna Aspesi; Suada Fröhlich; Pawel Szczęśniak; Philipp Lacher; Jörg Klug; Andreas Meinhardt; Günter Fingerle-Rowson; Rujun Gong; Zhihua Zheng; Anping Xu; Hui-Yao Lan
Journal:  Mol Ther       Date:  2018-07-17       Impact factor: 11.454

10.  Induction of macrophage migration inhibitory factor in ConA-stimulated rheumatoid arthritis synovial fibroblasts through the P38 map kinase-dependent signaling pathway.

Authors:  Hae-Rim Kim; Mi-Kyung Park; Mi-La Cho; Kyoung-Woon Kim; Hye-Joa Oh; Jin-Sil Park; Yang-Mi Heo; Sang-Heon Lee; Ho-Youn Kim; Sung-Hwan Park
Journal:  Korean J Intern Med       Date:  2010-08-31       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.